Progress of Biosynthesis of Morphine and Its Industrial Manufacture

FAN ChuYao,LIU LongYing,SHEN Yue,CHEN Tai,ZENG XiaoFan,YANG HuanMing

DOI: https://doi.org/10.1360/n972015-01206

2016-01-01

Chinese Science Bulletin (Chinese Version)

Abstract:Benzylisoquinoline alkaloids (BIA) are a diverse family of nitrogen-containing plant-specialized secondary metabolites.Morphine is one subclass of BIAs produced in only a few plant species,which is the most abundant analgesic opiate found in the opium poppy.Morphine has been used as a pain reliever for years and has been classified by WHO (World Health Organization) as an essential medicine due to its use in pain management and palliative care.However,the supply of morphine is not adequate to the demand in the world,especially in the developing areas.The primary source of morphine is the extraction from poppy straw of the opium poppy,but yields are poor because the metabolites accumulate at low levels in plant cells.An alternative way of producing morphine is chemical synthesis,but this way is high-cost and hampered by the complexity and chirality of morphine.As such,the reconstruction of morphine biosynthetic pathways in microorganisms has attracted more and more researchers in recent studies,because microbial systems can improve not only the quantity but also the quality of products.The developments in synthetic biology,combined with continued process in systems biology and metabolic engineering,have enabled the engineering of microorganisms to produce morphine in a manner that was previously unfeasible.And the biosynthesis of morphine is regarded as the most representative example after the successful biosynthesis of artemisinin.A number of recent reports have successfully reconstituted BIA pathways into Saccharomyces.cerevisiae,Escherichia.coli and combinations there of in co-culture systems.According to these reports,we clarified the related metabolic pathways and synthesis design of the morphine biosynthesis in microbial systems in this review.We divided the whole morphine biosynthesis pathway into three modules:module (i) is the synthesis of L-tyrosine fromsugar;module (ii) is the production of (S)-reticuline from L-tyrosine;and module (iii) is the synthesis of morphine from (S)-reticuline including the configuration transformation of (S)-reticuline to (R)-reticuline.In module (i),more work has been done in E.coli than in yeast to achieve high L-tyrosine production.However,given the limited ability of bacterial hosts to functionally express endomembrane-localized enzymes,such as plant cytochrome P450s that are prevalent in BIA biosynthesis,no steps downstream of (S)-reticuline have been demonstrated in E.coli.S.cerevisiaeis preferred to be the host because of its stable expression of many heterologous enzymes for the extensive BIA biosynthesis pathways,as a result of which,module (ii) and module (iii) have been reconstructed in S.cerevisiae for morphine production.And then we displayed the complete biosynthesis of morphine from sugarin yeast based on the study of Smolke'team,who engineered yeast with a medley of plant,bacterial,and rodent genes to turn sugar into the baine.Finally,we put forward some suggestions to optimize the pathway,including the modification of enzymes and the use of scaffold proteins.In this review,we not only showed the whole process of the landmark work,but also discussed the potentials and future prospects of synthetic biology for industrial manufacture.